SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-021464
Filing Date
2021-11-03
Accepted
2021-11-03 16:11:48
Documents
78
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q auph-20210930.htm   iXBRL 10-Q 1245339
2 EX-31.1 auph-2021q3exx311.htm EX-31.1 10973
3 EX-31.2 auph-2021q3exx312.htm EX-31.2 11115
4 EX-32.1 auph-2021q3exx321.htm EX-32.1 5445
5 EX-32.2 auph-2021q3exx322.htm EX-32.2 5453
  Complete submission text file 0001628280-21-021464.txt   6043171

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20210930.xsd EX-101.SCH 39252
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20210930_cal.xml EX-101.CAL 69722
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20210930_def.xml EX-101.DEF 161295
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20210930_lab.xml EX-101.LAB 505098
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20210930_pre.xml EX-101.PRE 322774
11 EXTRACTED XBRL INSTANCE DOCUMENT auph-20210930_htm.xml XML 1042485
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 211375476
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences